Skip to main content

Announcement from the Chair of the Cell Therapies Board

By October 13, 2021October 15th, 2021No Comments

The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle Burke has been appointed as a Non-Executive Director of Cell Therapies Pty Ltd.

“Michelle has extensive Board and Executive experience in the pharmaceuticals and biotechnology sector.  She has served for nine years as a Non-Executive Director and more recently as Chair of AusBiotech Ltd, the peak industry body supporting global growth of Australian life sciences organisations.  She is a member of Pharmaceutical Benefits Advisory Committee (PBAC), an independent expert body appointed by the Australian Government, and of the Strategic Advisory Group of the Australian Brain Cancer Mission established with the support of the Medical Research Future Fund.

Michelle is a significant contributor and industry advisor to cross-sectoral groups through her leadership of Indigo Advisory, an independent consultancy serving life sciences companies, academia and government, and which specialises in policy engagement,  innovation and commercialisation strategy. Previous executive experience includes more than two decades as a director with multinational pharmaceutical companies, most recently with Bristol-Myers Squibb spanning commercial, market access and advocacy leadership.

Michelle is a Graduate of the Australian Institute of Company Directors and has a Bachelor of Science (Hons) in Pharmacology.

Cell Therapies is currently undergoing a large transformational change which will see the organisation capitalise on its expertise within the global cell and gene therapy (CGT) market to become a high volume, large scale commercial Contract Development and Manufacturing Organisation (CDMO) supplying Australian and international patients.

Michelle’s experience and expertise across the pharmaceutical and biotechnology landscape coupled with her executive experience within the corporate setting will help build on Cell Therapies Pty Ltd past success and support in the delivery of an exciting future for the organisation.”

A/Prof Leslie Reti
Chairman of Cell Therapies Pty Ltd Board of Directors